the Effect of Different Oxaliplatin Dose in Transarterial Infusion (TAI) in Unresectable Hepatocellular Carcinoma
NCT03777475 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 350
Last updated 2018-12-17
Summary
evaluate the effect of different oxaliplatin dose in TAI in treating unresectable HCC.
Conditions
Interventions
- PROCEDURE
-
transarterial infusion
transarterial infusion
Sponsors & Collaborators
-
Sun Yat-sen University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-07-01
- Primary Completion
- 2021-06-30
- Completion
- 2022-12-31
Countries
- China
Study Locations
More Related Trials
-
HAIC Plus Targeted Therapy and/or PD-1 Inhibitors for Unresectable Intrahepatic Cholangiocarcinoma
NCT05489692 ·Status: COMPLETED
-
The Impact on Survival of Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) Who Underwent Hepatectomy : A Random, Controlled, Stage III Clinical Trial.
NCT03368651 ·Status: RECRUITING ·Phase: PHASE3
-
Phase Ⅱ Study of HAIC of FOLFOX vs. Sorafenib in HCC Refractory to TACE
NCT03722498 ·Status: WITHDRAWN ·Phase: PHASE2
-
Transarterial Infusion of PD-1 Antibody Plus TACE-HAIC for Unresectable HCC: a Single-arm, Phase 2 Clinical Trial
NCT04814030 ·Status: UNKNOWN ·Phase: PHASE2
-
Hepatic Arterial Infusion Combined With Lenvatinib and Camrelizumab for Unresectable Hepatocellular Carcinoma
NCT05003700 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of CD147-targeted CAR-T by Hepatic Artery Infusions for Very Advanced Hepatocellular Carcinoma
NCT03993743 ·Status: UNKNOWN ·Phase: PHASE1
-
HAIC Plus PD-1 Antibody vs HAIC Plus Sorafenib for Advanced HCC
NCT03780634 ·Status: WITHDRAWN ·Phase: PHASE2
-
The Impact on Survival of Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Beyond Milan Criteria BCLC Stage A/B Hepatocellular Carcinoma Who Underwent Hepatectomy
NCT03851913 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study of the Application of HAIC in Advanced HCC Previously Treated With ICIs and Antiangiogenic Agents
NCT05718492 ·Status: RECRUITING ·Phase: NA
-
Immune Checkpoint Inhibitor Monotherapy or Combined With Molecular Targeted Drugs / Locoregional Therapy in the Treatment of Hepatocellular Carcinoma
NCT05609695 ·Status: UNKNOWN
-
The Efficacy of Transarterial Chemoinfusion (TAI) Combine Toripalimab in Advanced Hepatocellular Carcinoma (HCC)
NCT03851939 ·Status: UNKNOWN ·Phase: PHASE2
-
HAIC of FOLFOX vs. HAIC of OXA for Advanced HCC
NCT03468231 ·Status: UNKNOWN ·Phase: PHASE3
-
The Efficacy of Transarterial Chemoinfusion (TAI) Combine Lenvatinib in Advanced Hepatocellular Carcinoma (HCC)
NCT04053985 ·Status: UNKNOWN ·Phase: PHASE3
-
The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And Microvascular Invasion (MVI) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial.
NCT03192618 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy of Target - Immunotherapy and XELOX Chemotherapy for Advanced HCC
NCT06818097 ·Status: COMPLETED
-
SBRT+TACE+Sorafenib Vs Sorafenib in the Treatment of uHCC With PVTT
NCT04387695 ·Status: UNKNOWN ·Phase: PHASE3
-
Efcacy and Safety of Postoperative Adjuvant Hepatic Arterial Infusion Chemotherapy With mFOLFOX in Hepatocellular Carcinoma With High-risk Recurrence Factors
NCT07337421 ·Status: RECRUITING ·Phase: PHASE2
-
Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma Beyond Milan/UCSF Criteria Who Underwent Liver Transplantation
NCT04595864 ·Status: RECRUITING ·Phase: PHASE3
-
Oxaliplatin and Raltitrexed Treatment of Colorectal Cancer With Liver Metastases
NCT02557490 ·Status: UNKNOWN ·Phase: PHASE4
-
Study of PolyIC and PD-1 mAb in Subjects With Unresectable Hepatocellular Carcinoma
NCT03732547 ·Status: UNKNOWN ·Phase: PHASE2
-
Phase II Study of HAIC Using Cisplatin,Leucovorin and 5-Fluorouracil
NCT02987699 ·Status: UNKNOWN ·Phase: PHASE2
-
Anti-PD-1therapy Combined With Thermal Ablation for Advanced HCC
NCT03939975 ·Status: COMPLETED ·Phase: PHASE2
-
The Safety and Efficacy of Deferoxamine for Treating Unresectable Hepatocellular Carcinoma
NCT03652467 ·Status: UNKNOWN ·Phase: PHASE1
-
Lenvatinib for Unresectable Intrahepatic Cholangiocarcinoma
NCT03801499 ·Status: WITHDRAWN ·Phase: PHASE2
-
Systemic Chemotherapy Plus Lenvatinib and Toripalimab for HCC With Extrahepatic Metastasis
NCT04170179 ·Status: UNKNOWN ·Phase: PHASE2